← Back to Search

Treatment for Asthma (SARP3 Trial)

N/A
Waitlist Available
Led By W. Gerald Teague, MD
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 3 years
Awards & highlights

Summary

The overall goal of this proposal is to better understand the basis of airway remodeling in severe asthma and how remodeling changes overtime. The investigators propose to study a well characterized cohort of individuals with severe asthma using a multidisciplinary state-of-the-art-approach.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lung Function
Secondary study objectives
Asthma Control Questionnaire
Exacerbation
Puberty Changes

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
771 Previous Clinical Trials
1,284,197 Total Patients Enrolled
10 Trials studying Asthma
691 Patients Enrolled for Asthma
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,834,107 Total Patients Enrolled
280 Trials studying Asthma
114,088 Patients Enrolled for Asthma
Case Western Reserve UniversityOTHER
304 Previous Clinical Trials
246,951 Total Patients Enrolled
6 Trials studying Asthma
4,769 Patients Enrolled for Asthma
~8 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top